相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。High-resolution mapping of epitopes on the C2 domain of factor VIII by analysis of point mutants using surface plasmon resonance
Phuong-Cac T. Nguyen et al.
BLOOD (2014)
Inhibitors - cellular aspects and novel approaches for tolerance
D. W. Scott
HAEMOPHILIA (2014)
Structure of the factor VIII C2 domain in a ternary complex with 2 inhibitor antibodies reveals classical and nonclassical epitopes
Justin D. Walter et al.
BLOOD (2013)
A novel B-domain O-glycoPEGylated FVIII (N8-GP) demonstrates full efficacy and prolonged effect in hemophilic mice models
Henning R. Stennicke et al.
BLOOD (2013)
The diversity of the immune response to the A2 domain of human factor VIII
Rebecca C. Markovitz et al.
BLOOD (2013)
Characterization and Solution Structure of the Factor VIII C2 Domain in a Ternary Complex with Classical and Non-classical Inhibitor Antibodies
Justin D. Walter et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Factor VIII C1 Domain Spikes 2092-2093 and 2158-2159 Comprise Regions That Modulate Cofactor Function and Cellular Uptake
Esther Bloem et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Replacing the Factor VIII C1 Domain with a Second C2 Domain Reduces Factor VIII Stability and Affinity for Factor IXa
Hironao Wakabayashi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
The Reversal of Inhibitors in Congenital Hemophilia
Sean R. DeFrates et al.
PHARMACOTHERAPY (2013)
Conservative mutations in the C2 domains of factor VIII and factor V alter phospholipid binding and cofactor activity
Gary E. Gilbert et al.
BLOOD (2012)
Pharmacokinetics and safety of OBI-1, a recombinant B domain-deleted porcine factor VIII, in subjects with haemophilia A
C. L. Kempton et al.
HAEMOPHILIA (2012)
A membrane-interactive surface on the factor VIII C1 domain cooperates with the C2 domain for cofactor function
Junhong Lue et al.
BLOOD (2011)
MolProbity: all-atom structure validation for macromolecular crystallography
Vincent B. Chen et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2010)
Features and development of Coot
P. Emsley et al.
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2010)
PHENIX: a comprehensive Python-based system for macromolecular structure solution
Paul D. Adams et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2010)
Rational design of a fully active, long-acting PEGylated factor VIII for hemophilia A treatment
Baisong Mei et al.
BLOOD (2010)
Trp2313-His2315 of Factor VIII C2 Domain Is Involved in Membrane Binding STRUCTURE OF A COMPLEX BETWEEN THE C2 DOMAIN AND AN INHIBITOR OF MEMBRANE BINDING
Zhuo Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Factor VIII Lacking the C2 Domain Retains Cofactor Activity in Vitro
Hironao Wakabayashi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
A human FVIII inhibitor modulates FVIII surface electrostatics at a VWF-binding site distant from its epitope
J. D. Dimitrov et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Nonclassical anti-C2 domain antibodies are present in patients with factor VIII inhibitors
Shannon L. Meeks et al.
BLOOD (2008)
The tertiary structure and domain organization of coagulation factor VIII
Betty W. Shen et al.
BLOOD (2008)
The factor VIIIC1 domain contributes to platelet binding
Ting-Chang Hsu et al.
BLOOD (2008)
Antihuman factor VIIIC2 domain antibodies in hemophilia A mice recognize a functionally complex continuous spectrum of epitopes dominated by inhibitors of factor VIII activation
Shannon L. Meeks et al.
BLOOD (2007)
Neutralization of antifactor VIII inhibitors by recombinant porcine factor VIII
R. T. Barrow et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
The potential of aptamers as anticoagulants
SM Nirnjee et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2005)
Comparative immunogenicity of recombinant B domain-deleted porcine factor VII and Hyate:C in hemophilia A mice presensitized to human factor VIII
ET Parker et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2004)
Surface-exposed hemophilic mutations across the factor VIIIC2 domain have variable effects on stability and binding activities
PC Spiegel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Disruption of protein-membrane binding and identification of small-molecule inhibitors of coagulation factor VIII
PC Spiegel et al.
CHEMISTRY & BIOLOGY (2004)
The safety and efficacy of B-domain deleted recombinant factor VIII concentrate in patients with severe haemophilia A
JM Lusher et al.
HAEMOPHILIA (2003)
Optimization of factor VIII replacement therapy: Can structural studies help in evading antibody inhibitors?
PC Spiegel et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Inhibitor development in previously untreated patients with hemophilia A: A prospective long-term follow-up comparing plasma-derived and recombinant products
W Kreuz et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2002)
Four hydrophobic amino acids of the factor VIIIC2 domain are constituents of both the membrane-binding and von Willebrand factor-binding motifs
GE Gilbert et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Electrostatics of nanosystems: Application to microtubules and the ribosome
NA Baker et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Structure of a factor VIIIC2 domain-immunoglobulin G4κ Fab complex:: identification of an inhibitory antibody epitope on the surface of factor VIII
PC Spiegel et al.
BLOOD (2001)
Purity of factor VIII product and incidence of inhibitors in previously untreated patients with haemophilia A
EP Mauser-Bunschoten et al.
HAEMOPHILIA (2001)
The future of plasma-derived clotting factor concentrates
WK Hoots
HAEMOPHILIA (2001)
Investigation of porcine parvovirus among persons with hemophilia receiving Hyate:C porcine factor VIII concentrate
JM Soucie et al.
TRANSFUSION (2000)
分享论文
